A new branch on the tree: Next-generation sequencing in the study of cancer evolution

Seminars in Cell and Developmental Biology

Volumn 23, Issue 2, 2012, Pages 237-242

  Brosnan, Jacqueline A ^a   Iacobuzio Donahue, Christine A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Clonal evolution; High throughput; Metastasis; Next generation sequencing

Indexed keywords

DNA; RNA;

BASE PAIRING; CANCER CELL; CANCER GENETICS; CANCER INVASION; CANCER SURVIVAL; CARCINOGENESIS; CELL SURVIVAL; CLONAL EVOLUTION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA SEQUENCE; DRUG TARGETING; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CONSERVATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; KARYOTYPING; LYMPH NODE METASTASIS; METASTASIS; NEOPLASM; NONHUMAN; REVIEW; RNA SEQUENCE; SEQUENCE ANALYSIS;

EID: 84858799293     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2011.12.008     Document Type: Review

References (56)

1. Siegel R., Ward E., Brawley O., Jemal A. Cancer statistics, 2011. Cancer 2011, 61:212-236.
2. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
3. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., Li R.J., et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
4. Bueno R., De Rienzo A., Dong L., Gordon G.J., Hercus C.F., Richards W.G., et al. Second generation sequencing of the mesothelioma tumor genome. PloS One 2010, 5:e10612.
5. Chapman M.A., Lawrence M.S., Keats J.J., Cibulskis K., Sougnez C., Schinzel A.C., et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011, 471:467-472.
6. Jiao Y., Shi C., Edil B.H., de Wilde R.F., Klimstra D.S., Maitra A., et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011, 331:1199-1203.
7. Jones S., Wang T.-L., Shih I.-M., Mao T.-L., Nakayama K., Roden R., et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010, 330:228-231.
8. Jones S., Zhang X., Parsons D.W., Lin J.C.-H., Leary R.J., Angenendt P., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806.
9. Mardis E.R., Ding L., Dooling D.J., Larson D.E., McLellan M.D., Chen K., et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009, 361:1058-1066.
10. Parsons D.W., Jones S., Zhang X., Lin J.C.-H., Leary R.J., Angenendt P., et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
11. Parsons D.W., Li M., Zhang X., Jones S., Leary R.J., Lin J.C.-H., et al. The genetic landscape of the childhood cancer medulloblastoma. Science 2011, 331:435-439.
12. Wood L.D., Parsons D.W., Jones S., Lin J., Sjoblom T., Leary R.J., et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113.
13. Cahill D.P., Kinzler K.W., Vogelstein B., Lengauer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 1999, 9:M57-M60.
14. Nowell P.C. The clonal evolution of tumor cell populations. Science 1976, 194:23-28.
15. Fidler I.J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125-I-5-Iodo-2'-deoxyuridine. J Natl Cancer Inst 1971, 45:773-782.
16. Fidler I.J., Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977, 197:893-895.
17. Kripke M.L., Gruys E., Fidler I.J. Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res 1978, 38:2962-2967.
18. Cifone M.A., Fidler I.J. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci U S A 1981, 78:6949-6952.
19. Poste G., Tzeng J., Doll J., Greig R., Rieman D., Zeidman I. Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. Proc Natl Acad Sci U S A 1982, 79:6574-6578.
20. Talmadge J.E., Wolman S.R., Fidler I.J. Evidence for the clonal origin of spontaneous metastases. Science 1982, 217:361-363.
21. Kallioniemi A., Kallioniemi O., Sudar D., Rutovitz D., Gray J.W., Waldman F., et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821.
22. Armengol G., Capella G., Farre L., Peinado M.A., Miro R., Caballin M.R. Genetic evolution in the metastatic progression of human pancreatic cancer studied by CGH. Lab Invest 2001, 81:1703-1707.
23. Jiang J.-K., Chen Y.-J., Lin C.-H., Yu I.-T., Lin J.-K. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases-an analysis by comparative genomic hybridization. Genes Chromosomes Cancer 2005, 43:25-36.
24. Nishizaki T., DeVries S., Chew K., Goodson W.H., Ljung B.M., Thor A., et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 1997, 19:267-272.
25. Petersen S., Aninat-Meyer M., Schluns K., Gellert K., Dietel M., Petersen I. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer 2000, 82:65-73.
26. Schmidt-Kittler O., Ragg T., Daskalakis A., Granzow M., Ahr A., Blankenstein T.J.F., et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A 2003, 100:7737-7742.
27. Knosel T., Schluns K., Dietel M., Petersen I. Chromosomal alterations in lung metastases of colorectal carcinomas: associations with tissue specific tumor dissemination. Clin Exp Metastas 2005, 22:533-538.
28. Micci F., Haugom L., Ahlquist T., Abeler V.M., Trope C.G., Lothe R.A., et al. Tumor spreading to the contralateral ovary in bilateral ovarian carcinoma is a late event in clonal evolution. J Oncol 2010, 646340.
29. Kuukasjarvi T., Karhu R., Tanner M., Nupponen N., Pennanen S., Kallioniemi A., et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997, 29:1597-1604.
30. Harbst K., Staaf J., Masback A., Olsson H., Ingvar C., Vallon-Christersson J., et al. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns. Melanoma Res 2010, 20:381-391.
31. Blaker H., Graf M., Rieker R.J., Otto H.F. Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases. J Pathol 1999, 188:258-262.
32. Bonsing B.A., Corver W.E., Fleuren G.J., Cleton-Jansen A., Devilee P., Cornelisse C.J. Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases. Genes Chromosomes Cancer 2000, 28:173-183.
33. Jones T.D., Carr M.D., Eble J.N., Wang M., Lopez-Beltran A., Cheng L. Clonal origin of lymph node metastases in bladder carcinoma. Cancer 2005, 104:1901-1910.
34. Saric T., Braknac Z., Troyer D.A., Padalecki S.S., Sarodsy M., Williams K., et al. Genetic pattern of prostate cancer progression. Int J Cancer 1999, 81:219-224.
35. Barrett M.T., Sanchez C.A., Prevo L.J., Wong D.J., Galipeau P.C., Paulson T.G., et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999, 22:106-109.
36. Radford D.M., Phillips N.J., Fair K.L., Ritter J.H., Holt M., Donis-Keller H. Allelic loss and the progression of breast cancer. Cancer Res 1995, 55:5180-5183.
37. Baisse B., Bouzourene H., Saraga E.P., Bosman F.T., Benhattar J. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinomas. Int J Cancer 2001, 93:346-352.
38. Losi L., Baisse B., Bouzourene H., Benhattar J. Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 2005, 26:916-922.
39. Bagnara D., Callea V., Stelitano C., Morabito F., Fabris S., Neri A., et al. IgV gene intraclonal diversication and clonal evolution in B-cell chronic lymphocytic leukaemia. Br J Haematol 2006, 133:50-58.
40. Jones S., Chen W.-D., Parmigiani G., Diehl F., Beerenwinkel N., Antal T., et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A 2008, 105:4283-4288.
41. Yachida S., Jones S., Bozic I., Antal T., Leary R., Fu B., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467:1114-1117.
42. Meyerson M., Gabriel S., Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010, 11:685-696.
43. Campbell P.J., Stephens P.J., Pleasance E.D., O'Meara S., Li H., Santarius T., et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 2008, 40:722-729.
44. Chiang D.Y., Getz G., Jaffe D.B., Kelly M.J.T.O., Zhao X., Carter S.L., et al. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods 2009, 6:99-103.
45. Mortazavi A., Williams B.A., Mccue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008, 5:1-8.
46. Thomas R.K., Nickerson E., Simons J.F., Janne P.A., Tengs T., Yuza Y., et al. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing. Nat Med 2006, 12:852-855.
47. Campbell P.J., Pleasance E.D., Stephens P.J., Dicks E., Rance R., Goodhead I., et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A 2008, 105:13081-13086.
48. Smith A.E., Mohamedali A.M., Kulasekararaj A., Lim Z., Gaken J., Lea N.C., et al. Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Blood 2010, 116:3923-3932.
49. Navin N., Kendall J., Troge J., Andrews P., Rodgers L., McIndoo J., et al. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94.
50. Lee W., Jiang Z., Liu J., Haverty P.M., Guan Y., Stinson J., et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010, 465:473-477.
51. Stephens P.J., Greenman C.D., Fu B., Yang F., Bignell G.R., Mudie L.J., et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144:27-40.
52. Gould S.J., Eldredge N. Punctuated equilibria: the tempo and mode of evolution reconsidered. Paleobiology 1977, 3:115-151.
53. Shah S.P., Morin R.D., Khattra J., Prentice L., Pugh T., Burleigh A., et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813.
54. Campbell P.J., Yachida S., Mudie L.J., Stephens P.J., Pleasance E.D., Stebbings L.A., et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467:1109-1113.
55. Ding L., Ellis M.J., Li S., Larson D.E., Chen K., Wallis J.W., et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010, 464:999-1005.
56. Robbins C.M., Tembe W.A., Baker A., Sinari S., Moses T.Y., Beckstrom-Sternberg S., et al. Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Res 2011, 21:47-55.